This work is licensed under a
Creative Commons Attribution 4.0 International License
34. A.N. Orekhov, E.M. Pivovarova, I.A. Sobenin, V.V. Yakushkin and V.V. Tertov, Use of cell culture for optimisation of direct antiatherogenic therapy with verapamil, Drugs 44 Suppl 1 (1992) 105-110.
A.N. Orekhov, Direct anti-atherosclerotic therapy; development of natural antiatherosclerotic drugs preventing cellular cholesterol retention, " Curr. Pharm. Des. 19 (2013) 5909-5928.
I.A. Sobenin, D.A. Chistiakov, Y.V. Bobryshev and A.N. Orekhov, Blood atherogenicity as a target for anti-atherosclerotic therapy, Curr. Pharm. Des. 19 (2013) 5954-5962.
A.N. Orekhov, I.A. Sobenin, V.V. Revin and Y.V. Bobryshev, Development of antiatherosclerotic drugs on the basis of natural products using cell model approach, Oxid. Med. Cell Longev. 2015 (2015) 463797.
T.A. Shchelkunova, I.A. Morozov, P.M. Rubtsov, L.M. Samokhodskaya, I.V. Andrianova, E.G. Rudimov, I.A. Sobenin, A.N. Orekhov, A.N. Smirnov, Effect of sex hormones on levels of mRNAs coding for proteins involved in lipid metabolism in macrophages, Biochem (Mosc) 78 (2013).
A.N. Orekhov, V V. Tertov, S.N. Pokrovsky, I. Yu. Adamova, O.N. Martsenyuk, A.A. Lyakishev, V.N. Smirnov, Blood serum atherogenicity associated with coronary atherosclerosis. Evidence for nonlipid factor providing atherogenicity of lowdensity lipoproteins and an approach to its elimination, Circ Res. 62 (1988).
V.V. Tertov, A.N. Orekhov, I.A. Sobenin, Z.A. Gabbasov, E.G. Popov, A.A. Yaroslavov, V.N. Smirnov, Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation due to lipoprotein aggregation, Circ Res. 71 (1992).
D. Aksenov, D. Orekhova, R. Kireev, I. Andrianova, A. Smirnov, I. Sobenin, O. Panasenko, Effects of sex hormones on intracellular cholesterol accumulation and LDL aggregation, Abstracts of the 77th Congress of the European Atherosclerosis Society, 26-29 April 2008, Istanbul. Atheroscler Suppl. 9 (2008).
R.A. Kireev, E. Kuvshinova, I.V. Andrianova, I.A. Sobenin and A.N. Orekhov, Effect of sex hormones on atherosclerotic indices in primary culture of female cells, Abstracts of the 14th International Symposium on Atherosclerosis, 18-22 June 2006, Rome. Atheroscler Suppl. 7 (2006).
N.A. Nikitina, I.A. Sobenin, V.A. Myasoedova, VV Korennaya, AA Mel'nichenko, EM Khalilov, AN. Orekhov, Antiatherogenic effect of grape flavonoids in an ex vivo model, Bull Exp Biol Med 141 (2006) 712-715.
A.N. Orekhov, I.A. Sobenin, N.V. Korneev, T.V. Kirichenko, V.A. Myasoedova, A.A. Melnichenko, M. Balcells, E.R. Edelman, Y.V. Bobryshev, Anti-atherosclerotic therapy based on botanicals, Recent. Pat. Cardiovasc. Drug Discov. 8 (2013) 56-66.
L.H. Ryong, V.V. Tertov, A.V. Vasil'ev, V.A. Tutel'yan, and A.N. Orekhov, Antiatherogenic and antiatherosclerotic effects of mushroom extracts revealed in human aortic intima cell culture, Drug Dev. Res. 17 (1989) 109-117.
A.N. Orekhov, G.N. Baldenkov, V.V. Tertov, L.H. Ryong, S.G. Kozlov, A.A. Lyakishev, V.A. Tkachuk, M. Ya. Ruda, V.N. Smirnov, Cardiovascular drugs and atherosclerosis: Effects of calcium antagonists, betablockers, and nitrates on atherosclerotic characteristics of human aortic cells, J. Cardiovasc. Pharmacol. 12 Suppl 6 (1988).
S.V. Jargin, Cell Culture as a Testing System for Anti-Atherogenic Substances: A Brief Communication, Acta Pharm. Sci. 50 (2008) 237-240.
S.V. Jargin, Testing of serum atherogenicity on cell cultures: assessment of reliability, Gazz. Med. Ital. 170 (2011) 159-163.
S.V. Jargin, Testing of serum atherogenicity in cell cultures: questionable data published, Ger Med Sci. 10 (2012) Doc02.
S.V. Jargin, Orekhov's Method: Reassessment of in vitro lipid uptake assays, Recent Pat Cardiovasc Drug Discov. 9 (2015) 122-125.
A. Vogt, The genetics of familial hypercholesterolemia and emerging therapies, Appl Clin Genet. 8 (2015) 27-36.
J.L. Goldstein and M.S. Brown, The LDL receptor, Arterioscler Thromb Vasc Biol. 29 (2009) 431-438.
J.L. Goldstein and M.S. Brown, Progress in understanding the LDL receptor and HMG-CoA reductase, two membrane proteins that regulate the plasma cholesterol, J. Lipid Res. 25 (1984) 1450-1461.
R. Ricciarelli, J.M. Zingg and A. Azzi, Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells, Circulation. 102 (2000) 82-87.
V. Llorente-Cortés and L. Badimon, LDL receptor-related protein and the vascular wall: implications for atherothrombosis, Arterioscler. Thromb. Vasc. Biol. 25 (2005) 497-504.
Q. Gong and R.E. Pitas, Synergistic effects of growth factors on the regulation of smooth muscle cell scavenger receptor activity, J. Biol. Chem. 270 (1995) 21672-21678.
A. Pirillo, G.D. Norata and A.L. Catapano, LOX-1, OxLDL, and atherosclerosis, Mediators Inflamm. 2013 (2013) 152786.
S. Xu, S. Ogura, J. Chen, P.J. Little, J. Moss, and P. Liu, LOX-1 in atherosclerosis: biological functions and pharmacological modifiers, Cell Mol. Life Sci. 70 (2013) 2859-2872.
I.A. Sobenin, I.V. Andrianova, O.N. Demidova, T. Gorchakova, and A.N. Orekhov, Lipidlowering effects of time-released garlic powder tablets in double-blinded placebo-controlled randomized study, J. Atheroscler. Thromb. 15 (2008) 334-338.
H.K. Berthold and T. Sudhop, Garlic preparations for prevention of atherosclerosis, Curr. Opin. Lipidol. 9 (1998) 565-569.
M.H. Pittler and E. Ernst, Clinical effectiveness of garlic (Allium sativum), Mol. Nutr. Food Res. 51 (2007) 1382-1385.
M. Mahdavi-Roshan, A. Zahedmehr, A. Mohammad-Zadeh, HR Sanati, F Shakerian, A Firouzi, R Kiani, J. Nasrollahzadeh, Effect of garlic powder tablet on carotid intima-media thickness in patients with coronary artery disease: a preliminary randomized controlled trial, Nutr. Health. 22 (2013).
A.L. Vertkin, E.D. Li, I.A. Pyshkina and A.N. Orekhov, Role of fish food additives in the treatment and prophylaxis of atherogenic dyslipidemia, Kardiologiia 34 (1994) 22-28.
I. A. Sobenin, Principles of pathogenetic therapy of atherosclerosis. Dissertation, Research Institute for Pathology and Pathophysiology, Moscow, 2006. (Russian).
E.M. Pivovarova, Treatment of atherosclerosis, in: A.V. Pokrovsky (Ed. ), Clinical angiology, Moscow: Meditsina, vol. 2, p.2004) 712-714. (Russian).
S. Gorinstein, Z. Jastrzebski, J. Namiesnik, H. Leontowicz, M. Leontowicz and S. Trakhtenberg, The atherosclerotic heart disease and protecting properties of garlic: contemporary data, Mol. Nutr. Food Res. 51 (2007) 1365-1381.
M. Schneider, B. Loretz, M. Windbergs, N. Schneider-Daum, U.F. Schaefer and C. -M. Lehr, Biological barriers - Advanced drug delivery, in vitro modelling, and their implications for infection research, Eur. J. Pharm. Biopharm. 95 Pt A (2015) 1-2.